Inhibition of the Mitochondrial Permeability Transition by Aldehydes

• Published in: Biochemical and biophysical research communications 2002-02, Vol.291 (2), p.215-219
• Main Authors: Irwin, William A., Gaspers, Lawrence D., Thomas, John A.
• Format: Article
• Language: English
• Subjects: aldehyde; Aldehyde Dehydrogenase - metabolism; aldehydes; Aldehydes - pharmacology; Animals; Calcium Chloride - antagonists & inhibitors; dehydrogenase; fructose; Glyceraldehyde - pharmacology; hepatocytes; Intracellular Membranes - drug effects; Intracellular Membranes - metabolism; Ion Channels; Kinetics; Membrane Proteins - antagonists & inhibitors; Mitochondria, Liver - drug effects; Mitochondria, Liver - metabolism; Mitochondrial Membrane Transport Proteins; mitochondrial permeability transition; Permeability - drug effects; Phenylglyoxal - pharmacology; Rats
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1006/bbrc.2002.6457

Fructose has been shown to protect hepatocyte viability during hypoxia or exposure to mitochondrial electron transport inhibitors. We report here that the fructose metabolite d-glyceraldehyde (d-GA) is a good inhibitor of the mitochondrial permeability transition pore (PTP) in isolated rat liver mitochondria. We propose that a substantial portion of the protective effect of fructose on hepatocytes is due to d-GA inhibition of the permeability transition. Aldehydes which are substrates of the mitochondrial aldehyde dehydrogenase (mALDH) afford protection, while poor substrates do not. Protection is prevented by the ALDH inhibitor chloral hydrate. We propose that the NADH/NAD+ ratio is the key to protection. The aldehydes phenylglyoxal (PGO) and 4-hydroxynonenal (4-HNE), which have previously been shown to inhibit the PTP, apparently function by a different mechanism independent of mALDH activity. Both PGO or 4-HNE are themselves potent inhibitors of ALDH, and their protective effect cannot be blocked by an ALDH inhibitor.